Kee Diagnostics Private Limited - Due diligence report

A 360° intelligence report on Kee Diagnostics Private Limited: trust score, financial health, credit view, compliance, directors, growth and…

2004-08-16 New Delhi, Delhi Active Unlisted Active Compliant
Share
View plans Plan
KD Kee Diagnostics Private Limited
View plans Plan
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹349 50% off New user
Or enjoy up to 50% off with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Kee Diagnostics Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
68/100
Trust Score
Moderate

Kee Diagnostics Private Limited is assessed as Moderate with a Trust Score of 68/100. Kee Diagnostics Private Limited is an active private limited indian non-government company incorporated in 2004, operating in the Healthcare sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and moderate financial risk profile.

Report generated on 13 Jul 2026 from the latest processed filings. Kee Diagnostics Private Limited snapshot & full profile →

Financial Health › Neutral
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Neutral

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
68/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
51/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
50/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
55/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
85/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
70/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 55/100 Moderate
  • Liabilities ≈ 38% EBITDA - stretched.
  • No open charges - unencumbered balance sheet.
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 51/100 Moderate
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2024).
  • Flagged by authority: EPFO.
  • Litigation present in 1 court forum(s).
  • 1 active GST registration(s).
Legal cases on record (1)
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
SAMIR BISWAS 01234567 Director 01/04/2018 6 yrs Approved
ANIL MOTIHAR 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2022)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Kee Pharma Limited
Subsidiaries
-
Group entities
-
Capital events
2 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Kee Pharma Limited Holding Company 74.00%

Key managerial personnel: SAMIR BISWAS (Managing Director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 85 · Distress 70
Growth signals & trust indicators
Steady revenue growth: +1.42 over 4 year(s).
Latest year revenue grew 2.1x.
Profit expanded 24% year-on-year.
Net margin improved to 0.86.
Operating for 21+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Negative net worth.
Compliance score is weak (51/100).
1 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence62/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment52/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance gaps should be priced into terms.
Investor view68/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 4 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 13 events
29 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2024
Latest balance sheet
Filed with ROC
04 Sep 2021
Director ceased
SAMIR BISWAS
30 Sep 2019
Director ceased
MAYANK RASTOGI
29 Sep 2018
Director ceased
RAJEEV BAHL
19 Jun 2018
Director ceased
VARUN MOTIHAR
15 Apr 2018
Director appointed
SAMIR BISWAS (Managing Director)
31 Mar 2015
Director ceased
PRASANTA KUMAR GHOSH
25 Nov 2011
Securities allotted
2027000.00 Equity Shares - 2.03 cr raised
03 Dec 2009
Director ceased
HARINDER MOTIHAR
31 Mar 2009
Securities allotted
770000.00 Equity Shares - 77.00 Lakh raised
16 Aug 2004
Incorporated
Registered with Roc Delhi
Director appointed
ANIL MOTIHAR (Director)
10

Key Observations

Auto-generated from the data above
Revenue grew 61% over the last 4 financial year(s).
Net profit margin moved from 38% to 1.42.
2 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 2 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Ptcgram Private Limited U24290MH2021PTC360281 Virar, Maharashtra, India
Mg Biological Private Limited U85190DL2021PTC389496 Delhi, Delhi, India
Rainbow Coating System Private Limited U36912MH2015PTC269056 Amravati, Maharashtra, India
Vishnu Life Sciences Limited U24231TG1995PLC019242 Hyderabad, Telangana, India
Protech Animal Health Private Limited U24299GJ2021PTC121503 Rajkot, Gujarat, India
Nandini Skin Care Private Limited U24290DL2021PTC379179 New Delhi, Delhi, India
Meghna Rasayan Private Limited U24100WB2014PTC203333 Kolkata, West Bengal, India
Gmh Pharmaceuticals Pvt Ltd U24232CH1994PTC014857 Chandigarh, Chandigarh, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Kee Diagnostics Private Limited before audits and certifications: compliance score 51/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Kee Diagnostics Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 55/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 85/100, margin trends, ownership structure and peer set for Kee Diagnostics Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 68/100, distress signals and MSME payment-delay disclosures - know whether Kee Diagnostics Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Kee Diagnostics Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Kee Diagnostics Private Limited an active company?

Kee Diagnostics Private Limited has MCA status “Active” with a compliance score of 51/100 (Moderate).

Is Kee Diagnostics Private Limited financially healthy?

Kee Diagnostics Private Limited has a Financial Health Score of 50/100 (Moderate) based on its filed financial statements.

Should I do business with Kee Diagnostics Private Limited?

Its overall Trust Score is 68/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Kee Diagnostics Private Limited?

The ultimate holding entity is Kee Pharma Limited. 2 active director(s) are on record.

Does Kee Diagnostics Private Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Kee Diagnostics Private Limited up to date with its ROC filings?

Balance sheet slightly behind (Mar 2024). Overall compliance score: 51/100 (Moderate).

Is it risky to lend to Kee Diagnostics Private Limited?

Its Credit Risk Score is 55/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.